USPTO serial 98768671
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $600
Cambridgeshire, GB
Cambridgeshire, GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew J. Avsec
P.O. Box 10395Chicago, IL 60610United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biological, and biotechnological reagents for scientific laboratory use and medical laboratory use in the fields of life science, biotechnology and genomics; diagnostic and laboratory reagents for scientific purposes in the fields of life science, biotechnology and genomics; enzyme preparations for industrial purposes; enzymes for industrial purposes; industrial chemicals; biochemical catalysts; diagnostic preparations, other than for medical or veterinary purposes; biological preparations for use in industry and science, other than for medical or veterinary purposes; proteins for use in industry and science, namely, in recombinant DNA technology, other than for medical use; proteins in raw material form for medical research, namely, proteins for use in recombinant DNA technology for use in medical laboratories; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads | ACTIVE | — |
| 005 | Chemicals, namely, chemical preparations and chemical reagents for medical purposes, to be used in medical laboratories and for medical diagnostic purposes; therapeutic and diagnostic reagents for medical use, namely, for use in medical laboratories and/or for medical diagnostic purposes; biochemical, biological, biotechnological reagents for medical use, namely, for use in medical laboratories and/or for medical diagnostic purposes; vaccine preparations; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads | ACTIVE | — |
| 009 | Scientific laboratory research instruments for measuring, analyzing and quantifying chemical, biochemical and biological components for genomic and nucleic acid research; scientific apparatus and instruments for the detection and analysis of nucleic acids; scientific research kits for measuring, analyzing, and quantifying chemical, biochemical, and biological components for genomic and nucleic acids research primarily comprised of thermometers not for medical purposes, test tubes, spectrometers, mass spectrometers, DNA analyzers, electrochemical monitors for laboratory use, DNA sequencers, electrophoresis instruments not for medical purposes, DNA extractors; computer software applications, downloadable, for manufacturing and research in the field of synthetic DNA and RNA design and synthesis, non-viral vector development, process control and data analysis in the field of medical research; material testing instruments and machines, namely, electronic apparatus for testing synthetic DNA and RNA and non-viral vectors; diagnostic apparatus, not for medical purposes, namely, diagnostic apparatus for testing synthetic DNA and RNA; chemistry apparatus and instruments, namely, flasks for laboratory use, electronic chemical analyzers for testing and analyzing chemical substances for the presence, absence, or quantity of target chemicals, chemistry apparatus for detecting and analysing DNA and RNA, not for medical purposes; DNA chips; surveying apparatus and instruments; bioreactors for laboratory use; genetic testing apparatus for scientific use, namely, laboratory devices for detecting genetic sequences; laboratory apparatus for detecting genetic sequences; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads | ACTIVE | — |
| 042 | Laboratory research services in the fields of life science, biotechnology and genomics; scientific research services in the fields of life science, biotechnology and genomics; biological, biotechnological, chemical and biochemical scientific research and development services in the fields of life science, biotechnology and genomics; contract research services for others in the fields of life science, biotechnology and genomics; scientific and research and development services in the field of nucleic acids; scientific research and development services for drugs and pharmaceutical discovery and research in the field of genomics and nucleic acids; scientific research services in the field of nucleic acids for therapeutic or diagnostic use; design of synthetic DNA, genes and oligonucleotides for others; scientific research in the field of genetics; scientific research and development services in the field of genomics; scientific research and development services relating to vaccines and medicines; all of the aforesaid only to be used in connection to the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 3, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 20, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 24, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 24, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 18, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 2, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 31, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 6, 2025 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 6, 2025 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Mar 6, 2025 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Sep 25, 2024 | NWAP | NEW APPLICATION ENTERED | — |